Search

everythinglearnresearchcommunity

for

Search:↓

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

An addax had skin cancer that spread to lymph nodes and was euthanized.

Chemotherapy caused nail grooves and separation, but they healed after treatment stopped.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Sudden, unusual hair loss may indicate serious underlying health issues.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

A 69-year-old smoker was wrongly diagnosed with lung cancer but actually had a rare lymphatic system disorder.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

New insights into cell communication in psoriasis suggest innovative drug treatments.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."